$1.04
9.57% today
Nasdaq, Apr 04, 08:45 pm CET
ISIN
US5560991094
Symbol
MGNX
Sector
Industry

MacroGenics, Inc. Target price 2025 - Analyst rating & recommendation

MacroGenics, Inc. Classifications & Recommendation:

Buy
38%
Hold
63%

MacroGenics, Inc. Price Target

Target Price $5.80
Price $1.15
Potential
Number of Estimates 5
5 Analysts have issued a price target MacroGenics, Inc. 2026 . The average MacroGenics, Inc. target price is $5.80. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 8 analysts: 3 Analysts recommend MacroGenics, Inc. to buy, 5 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the MacroGenics, Inc. stock has an average upside potential 2026 of . Most analysts recommend the MacroGenics, Inc. stock at Hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 149.96 62.49
155.25% 58.33%
Net Margin -44.82% -258.36%
179.46% 476.39%

6 Analysts have issued a sales forecast MacroGenics, Inc. 2025 . The average MacroGenics, Inc. sales estimate is

$62.5m
Unlock
. This is
58.33% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$174m 16.26%
Unlock
, the lowest is
$21.2m 85.86%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $150m 155.25%
2025
$62.5m 58.33%
Unlock
2026
$84.6m 35.42%
Unlock
2027
$54.3m 35.89%
Unlock
2028
$91.4m 68.55%
Unlock
2029
$87.0m 4.84%
Unlock

7 MacroGenics, Inc. Analysts have issued a net profit forecast 2025. The average MacroGenics, Inc. net profit estimate is

$-161m
Unlock
. This is
137.97% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-39.6m 41.66%
Unlock
, the lowest is
$-198m 191.66%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-67.2m 613.33%
2025
$-161m 140.19%
Unlock
2026
$-110m 31.75%
Unlock
2027
$-143m 29.79%
Unlock
2028
$-157m 10.03%
Unlock
2029
$-137m 12.77%
Unlock

Net Margin

2024 -44.82% 179.46%
2025
-258.36% 476.39%
Unlock
2026
-130.20% 49.61%
Unlock
2027
-263.61% 102.47%
Unlock
2028
-172.09% 34.72%
Unlock
2029
-157.74% 8.34%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -1.07 -2.57
613.33% 140.19%
P/E negative
EV/Sales negative

7 Analysts have issued a MacroGenics, Inc. forecast for earnings per share. The average MacroGenics, Inc. EPS is

$-2.57
Unlock
. This is
137.96% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.63 41.67%
Unlock
, the lowest is
$-3.15 191.67%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-1.07 613.33%
2025
$-2.57 140.19%
Unlock
2026
$-1.75 31.91%
Unlock
2027
$-2.28 30.29%
Unlock
2028
$-2.51 10.09%
Unlock
2029
$-2.19 12.75%
Unlock

P/E ratio

Current -1.07 98.89%
2025
-0.45 57.94%
Unlock
2026
-0.66 46.67%
Unlock
2027
-0.51 22.73%
Unlock
2028
-0.46 9.80%
Unlock
2029
-0.53 15.22%
Unlock

Based on analysts' sales estimates for 2025, the MacroGenics, Inc. stock is valued at an EV/Sales of

-1.47
Unlock
and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current -0.61 104.96%
2025
-1.47 140.46%
Unlock
2026
-1.08 26.16%
Unlock
2027
-1.69 55.99%
Unlock
2028
-1.00 40.67%
Unlock
2029
-1.05 5.09%
Unlock

P/S ratio

Current 0.48 96.91%
2025
1.16 139.98%
Unlock
2026
0.86 26.16%
Unlock
2027
1.34 55.98%
Unlock
2028
0.79 40.67%
Unlock
2029
0.83 5.09%
Unlock

Current MacroGenics, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
HC Wainwright & Co.
Locked
Locked
Locked Mar 25 2025
JMP Securities
Locked
Locked
Locked Nov 07 2024
HC Wainwright & Co.
Locked
Locked
Locked Nov 06 2024
HC Wainwright & Co.
Locked
Locked
Locked Sep 18 2024
HC Wainwright & Co.
Locked
Locked
Locked Aug 21 2024
Analyst Rating Date
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 25 2025
Locked
JMP Securities:
Locked
Locked
Nov 07 2024
Locked
HC Wainwright & Co.:
Locked
Locked
Nov 06 2024
Locked
HC Wainwright & Co.:
Locked
Locked
Sep 18 2024
Locked
HC Wainwright & Co.:
Locked
Locked
Aug 21 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today